NANCY OLIVER: Open Payments
NPI 1447577614 · CAMBRIDGE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$179 in 9 payments from 7 companies in 2025. Trend: 2023 $181 · 2024 $218 · 2025 $179
Food & beverage: $179
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $43 |
| Lilly USA, LLC | 2 | $39 |
| Lundbeck LLC | 1 | $25 |
| ABBVIE INC. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: MOUNJARO, REXULTI, QULIPTA, ELIQUIS, PREVNAR 20, AIRSUPRA, SHINGRIX, OTEZLA.
Industry payments across MD — which companies pay providers there.
